Springer Nature
Browse
12985_2019_1140_MOESM3_ESM.pdf (5.8 kB)

Additional file 3: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

Download (5.8 kB)
journal contribution
posted on 2019-03-14, 05:00 authored by Mingshu Li, Jun Chen, Zhixiong Fang, Yi Li, Qian Lin
Figure S3. Forest plots showing the results of subgroup analysis result of SVR12/24 in studies applied 200 mg QD sofosbuvir or 400 mg/48 h sofosbuvir. (PDF 5 kb)

History

Usage metrics

    Virology Journal

    Categories

    Keywords

    HCV infectionStage 4–5 chronic kidney diseaseSofosbuvirDoseMeta-analysis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC